Mechanism of action biomarkers predicting response to AKT inhibition in the I-SPY 2 breast cancer trial
Denise M. Wolf, Laura van ‘t Veer, Lamorna Brown Swigart(University of California, San Francisco), Julia Wulfkuhle(University of California, San Francisco), Smita Asare(Quantum Leap Healthcare Collaborative), A. Jo Chien(University of California, San Francisco), Rosa I. Gallagher(George Mason University), Christina Yau(Hospital Authority), Mark Jesus M. Magbanua(University of California, San Francisco), Laura J. Esserman(University of California, San Francisco), Gillian L. Hirst(University of California, San Francisco), Don Berry(University of California, San Francisco), Nick O’Grady(University of California, San Francisco), Debu Tripathy(The University of Texas MD Anderson Cancer Center), Emanuel F. Petricoin(Center for Biologics Evaluation and Research)
Cited by 35
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
The Immune Landscape of Cancer
|Immunity|2018|6.3k
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
|Cell|2018|4k